Department of Neuroradiology, CHRU Tours, Tours, France.
Department of Neuroradiology, Hôpital Maison Blanche, CHU Reims, Reims, France.
J Neurointerv Surg. 2022 Nov;14(11):1090-1095. doi: 10.1136/neurintsurg-2021-018188. Epub 2021 Nov 18.
Scientific data on the safety and efficacy of flow diverter stents (FDS) for the treatment of unruptured internal carotid artery (ICA) aneurysms with compressive neuro-ophthalmological symptoms are scarce. We studied this subject in a retrospective international multicenter series, pooling data of 9 tertiary care neurointerventional departments.
To investigate, in a retrospective, multicentric cohort of patients presenting with visual or oculomotor symptoms attributed to a compressive carotid artery in an unruptured intracranial aneurysm, the safety and efficacy profiles of FDS, by analyzing neuro-opthalmologic symptom evolution following FDS placement, complications, and aneurysm obliteration rates.
All patients treated since 2015 with a FDS for an unruptured aneurysm of the ICA with signs of compressive cranial nerve symptoms (CN II, III, IV, VI) were included.
We treated 55 patients with 55 aneurysms; 21 (38.2%) patients had oculomotor and 15 (27.3%) visual symptoms only; 19 (34.5%) presented with a combination of both. Treatment-related morbidity/mortality occurred in 7.2% and 3.6%, respectively. At last imaging follow-up (13.1±10.5 months) rates of complete aneurysm occlusion, neck remnant, and aneurysm remnant were 72%, 14%, and 14%, respectively. At last clinical follow-up after 13±10.5 months, 19/51 (37.3%) patients had recovered completely and 18/51 (35.3%) had recovered at least partially from their neuro-ophthalmological symptoms. In multivariable models, a longer delay between symptom onset and treatment was associated with higher odds for incomplete recovery and lower odds for any improvement (aOR 1.03 (95% CI 1.01 to 1.07), p=0.047 and 0.04 (0-0.81), p=0.020). Incomplete recovery was independently associated with older age and fusiform aneurysms.
FDS are effective to treat patients with compressive aneurysms of the ICA causing neuro-ophthalmological symptoms, especially when treatment is initiated early after symptom onset, and aneurysm occlusion is adequate. However, serious complications are not rare.
关于血流导向装置(Flow Diverter Stents,FDS)治疗伴有压迫性神经眼科症状的未破裂颈内动脉(Internal Carotid Artery,ICA)动脉瘤的安全性和有效性的科学数据很少。我们在一个回顾性的国际多中心系列研究中研究了这个问题,汇集了 9 个三级神经介入治疗中心的数据。
通过分析 FDS 放置后神经眼科症状的演变、并发症和动脉瘤闭塞率,研究在伴有压迫性颈内动脉的未破裂颅内动脉瘤引起的视觉或眼肌运动症状的患者中,FDS 的安全性和有效性。
所有在 2015 年以后接受 FDS 治疗的未破裂颈内动脉动脉瘤患者,均伴有颅神经症状(CN II、III、IV、VI)的压迫迹象,均纳入研究。
共治疗 55 例 55 个动脉瘤患者;21 例(38.2%)患者有眼肌运动症状,15 例(27.3%)有视觉症状,19 例(34.5%)同时有两种症状。与治疗相关的发病率/死亡率分别为 7.2%和 3.6%。在最后一次影像学随访(13.1±10.5 个月)时,完全闭塞、瘤颈残留和动脉瘤残留的比例分别为 72%、14%和 14%。在最后一次临床随访(13±10.5 个月)后,51 例患者中有 19 例完全恢复,18 例至少部分恢复了神经眼科症状。多变量模型显示,症状出现与治疗之间的延迟时间越长,不完全恢复的可能性越高,任何改善的可能性越低(优势比 1.03(95%置信区间 1.01-1.07),p=0.047;0.04(0-0.81),p=0.020)。不完全恢复与年龄较大和梭形动脉瘤独立相关。
FDS 治疗伴有压迫性神经眼科症状的颈内动脉动脉瘤是有效的,尤其是在症状出现后早期开始治疗,且动脉瘤闭塞充分时。然而,严重的并发症并不罕见。